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Abstract:  26 
The next-generation short-read sequencing technologies that generate 27 
comprehensive, whole-genome data with single-nucleotide resolution have already 28 
advanced tuberculosis diagnosis, treatment, surveillance and source investigation. 29 
Their high costs, tedious and lengthy processes, and large equipment remain major 30 
hurdles for research use in high tuberculosis burden countries and implementation 31 
into routine care. The portable next-generation sequencing devices developed by 32 
Oxford Nanopore Technologies (ONT) are attractive alternatives due to their long-33 
read sequence capability, compact low-cost hardware, and continued improvements 34 
in accuracy and throughput. A systematic review of the published literature 35 
demonstrated limited uptake of ONT sequencing in tuberculosis research and clinical 36 
care. Of the 12 eligible articles presenting ONT sequencing data on at least one 37 
Mycobacterium tuberculosis sample, four addressed software development for long 38 
read ONT sequencing data with potential applications for M. tuberculosis. Only eight 39 
studies presented results of ONT sequencing of M. tuberculosis, of which five 40 
performed whole-genome and three did targeted sequencing. Based on these 41 
findings, we summarize the standard processes, reflect on the current limitations of 42 
ONT sequencing technology, and the research needed to overcome the main 43 
hurdles. Summary: The low capital cost, portable nature and continued 44 
improvement in the performance of ONT sequencing make it an attractive option for 45 
sequencing for research and clinical care, but limited data is available on its 46 
application in the tuberculosis field. Important research investment is needed to 47 













































Two decades after the genome sequence of Mycobacterium tuberculosis (Mtb) 50 
H37Rv was published, sequencing technologies can now generate comprehensive 51 
genomic data with unprecedented resolution, which makes them highly attractive for 52 
research, clinical care, and applications in tuberculosis (TB) control programs(1). 53 
While the implementation of Mtb sequencing has been facilitated by decreases in 54 
cost, technological advances, and improved bioinformatics to translate sequence 55 
data into biologically relevant information, the initial capital expenses of Illumina 56 
sequencing platforms, sequencing reagent costs, and the need for highly trained 57 
staff remain important hurdles for wide-spread implementation, especially in high TB 58 
burden countries(2).  59 
 60 
Long-read sequencing technologies are an enticing alternative to commonly-used 61 
short-read sequencing platforms as it allows for the analysis of complex genomic loci 62 
and large repetitive elements, both distinct characteristics of the Mtb genome(1). 63 
Analysing variation in these genomic regions could potentially provide a clearer 64 
understating of genes involved in host pathogen interactions and virulence. 65 
Moreover, nanopore sequencing, like PacBio single-molecule real-time (SMRT) 66 
sequencing (Pacific Biosciences, Menlo Park, California, United States), can also 67 
identify methylation status(3), which is important as epigenetic modifications in Mtb 68 
have been associated with drug resistance, virulence, and regulation of gene 69 
expression profiles(4, 5). Nanopore sequencing platforms developed by Oxford 70 
Nanopore Technologies (ONT), are especially attractive due to their low cost and 71 
portable hardware. The ONT MinION (Oxford Nanopore Technologies, Oxford, 72 












































sequencing reads in 48 hours in a decentralized laboratory(6). Recent reductions in 74 
error rates, updated flow cells, lower amounts of required input DNA, and faster 75 
library preparation protocols have renewed the interest in its use in TB research and 76 
clinical applications(7-9).  77 
 78 
We outline the unique aspects of ONT sequencing and performed a critical narrative 79 
systematic review of the published literature on ONT sequencing of Mtb to reflect on 80 
recent developments and future opportunities.  81 
 82 
ONT sequencing  83 
Nanopore sequencing is a unique, scalable technology that monitors changes in an 84 
electrical current as nucleic acids are passed through a nanopore protein. The 85 
resulting signal is decoded to provide the specific DNA or RNA sequence. The use of 86 
a nanopore for sequencing a single molecule of DNA or RNA negates the need for 87 
PCR amplification or chemical labeling of the sample for certain applications. The 88 
versatility of the platform and library preparation approaches allow for the 89 
sequencing of native nucleic acids, PCR libraries and amplified genomic targets. An 90 
overview of the general approach to the Mtb ONT sequencing process is shown in 91 
Figure 1. In this section, we briefly describe ONT flow cells, library preparation, base-92 
calling and bioinformatics analysis applicable to Mtb ONT sequencing.   93 
 94 
ONT Flow cell chemistry 95 
ONT Flow cells are designed to detect current signals from k-mers as the nucleic 96 
acid molecules move through the nanopore. The early R7 flow cell chemistry 97 












































while in R9 flowcells, this has been reduced to a 3-mer. Ignoring potential base-99 
modifications and assuming that only 4 different bases can be present corresponds 100 
to a reduction from 4096 (= 46) possible k-mers to 64 (43) possible k-mers during 101 
base-calling(10). In addition to pores that are occupied by shorter k-mers, dual 102 
reading of nucleotide sequences inside the pore was implemented in the latest R10 103 
flow cells, implying that sequences are associated with a current signal at two 104 
different points in space and time inside the pore, resulting in an improved resolution 105 
and improved base-calling of homopolymeric regions. 106 
 107 
Library preparation 108 
A wide range of sequencing kits and library preparation approaches are available for 109 
ONT sequencing, each recommended for specific applications, and requiring varying 110 
quantities of input material. For example, native DNA or RNA sequences can be 111 
detected in workflows without PCR-amplification but require 400-1000 ng of input 112 
DNA(11, 12). Amplification-based approaches are recommended by ONT when input 113 
DNA is limited in quantity or quality, when control over the read length is required, 114 
and for targeted amplicon sequencing. Unless input DNA is limited, fragmentation of 115 
input DNA is not necessary, leading to a read length equal to the fragment length of 116 
the input DNA(9). 117 
 118 
VolTRAX (Oxford Nanopore Technologies, Oxford, United Kingdom) is a portable 119 
automated sample preparation device that transforms biological samples into 120 
sequence-ready libraries and enables consistent library quality, even in the field or in 121 
the absence of elaborate laboratory infrastructure(9, 13, 14). VolTRAX is compatible 122 












































also developed rapid field sequencing kits to overcome the challenges associated 124 
with cold-chain transport of reagents. Together, these developments increase the 125 
speed and simplicity of library preparation and reduce the need for specialised 126 
laboratory equipment and enhance the possibility of moving sequencing into the field 127 
and closer to point of care(15). 128 
 129 
Base-calling 130 
ONT-sequencers monitor the changes in electrical current as nucleic acids pass 131 
through a nanopore protein. The resulting signals are stored in FAST5 files and are 132 
decoded during the ‘base-calling’ process, which translates the raw signals into 133 
nucleic acid sequences in FASTQ format(9). The electrical current signal reflects the 134 
presence of a k-length nucleotide sequence (k depending on the type of flow cell) 135 
passing through the nanopore. This makes base-calling of ONT sequencing data 136 
computationally more demanding, error-prone and complex than the simple one-to-137 
one conversion algorithm used by other sequencing technologies.  138 
 139 
The first base-callers used hidden Markov models to estimate the likelihood that an 140 
observed signal corresponds to a particular k-mer sequence inside the nanopore(3). 141 
More recent base-callers use machine learning or hybrid models for inferring k-mers 142 
from raw signal data. Machine learning models are mainly trained on sequencing 143 
data derived from Escherichia coli , although several base-callers (such as Guppy(9) 144 
and Chiron(16)) allow users to de novo train the algorithm. Ideally, a base-caller for 145 
Mtb would be trained on Mtb sequencing data with a known ground truth (reference 146 
sequence) so that base modifications found in Mtb (such as m6A and m5C(17)) and 147 













































Bioinformatic analysis  150 
Mtb ONT sequencing bioinformatics pipelines follow a similar approach to pipelines 151 
for short-read (e.g., Illumina) data, with quality control (read trimming), alignment to a 152 
reference genome, variant identification, and annotation to identify genomic variants 153 
for diagnosis of drug resistance or identification of transmission events(1). Some 154 
short-read pipelines (Mykrobe and TBProfiler) have already been updated to also 155 
analyse longer read sequence data(18, 19).  156 
 157 
In contrast to most short-read pipelines which align sequence reads to the reference 158 
genome, ONT sequence analysis pipelines typically include the option to perform de 159 
novo genome assembly (e.g. Flye(20)). An interesting but costly approach is a hybrid 160 
assembly(21) in which the (more error-prone) long reads are used to close gaps by 161 
linking contigs and resolving repeat regions and the (accurate) short reads are 162 
mapped to the assembled contigs to correct for sequencing errors. This approach 163 
has been used for Mtb(21) and is especially valuable for analysis of highly repetitive 164 
regions (such as pe/ppe regions), for detecting structural genome variation (e.g., 165 
inversion, insertions or deletions), and for deciphering the genomes of novel Mtb 166 
lineages.  167 
 168 
ONT sequencing for Mtb research and clinical care 169 
We performed a search of PubMed and Scopus on 20 Jan 2021 using the search 170 
terms “tuberculosis” or “Mycobacterium tuberculosis” and “nanopore” or “Oxford 171 
Nanopore Technologies” or “portable sequencing” without date or language 172 












































least one sample or if the development of bioinformatics tools for analysis of Mtb 174 
ONT data was described. We identified 58 articles of which 12 were eligible. Five 175 
articles focused on whole-genome sequencing (WGS)(8, 12, 21-23), three on 176 
targeted sequencing(11, 24, 25) (Table 1), and four on software development for 177 
long read ONT data with applications for Mtb(16, 18, 19, 26) (Table 2).  178 
 179 
Research applications 180 
The first ‘proof of principle’ study was published in 2016 and focussed on the 181 
development of an enrichment protocol of Mtb DNA for ONT sequencing(22). Eckert 182 
et al. mixed Mtb DNA (H37Rv and DNA from a clinical extensively drug-resistant 183 
strain) with human genomic DNA (at 10% and 90% Mtb DNA) and used biotinylated 184 
RNA baits synthesised based on Mtb H37Rv to capture long fragments of Mtb DNA. 185 
They reported that unenriched mixtures resulted in very low Mtb genome coverage 186 
while enrichment resulted in partial genome coverage. Areas with high coverage 187 
depth corresponded to open-reading frames encoding transposases, which may 188 
reflect redundancy of the captured sequence.  189 
 190 
In 2018, Bainomugisa et al. used ONT sequencing to investigate a Beijing strain that 191 
had caused outbreaks of drug-resistant TB in Papua New Guinea(21). By combining 192 
a complete ONT-based genome assembly with Illumina sequencing for error 193 
correction, Bainomugisa et al. identified all drug resistance-causing mutations, novel 194 
variation, including three previously undescribed genomic deletions (1315, 1355, 195 
1356 bp, respectively) and two insertions (390 and 4490 bp), multiple variants in 196 













































Clinical applications 199 
The largest clinical study of 431 cultured isolates was published in 2020(23). Smith 200 
et al. aimed to validate ONT for species identification, in silico spoligotyping, 201 
detection of drug resistance, and phylogenetic analysis. WGS on ONT MinION 202 
showed drug resistance profiles comparable to those obtained by Illumina MiSeq 203 
(96% and 96,2% respective concordance with phenotypic drug susceptibility testing), 204 
and with equal or faster turnaround time, and competitive per sample sequencing 205 
cost (±63 USD on ONT vs 130 USD for Illumina MiSeq). Small insertions and 206 
deletions and heterozygous variants were more difficult to ascertain with high 207 
accuracy using ONT data.  208 
 209 
A small study published in 2020 aimed to validate the ONT rapid sequencing kit for 210 
detection of drug-resistance in Mtb(8). Cervantes et al. observed that the number of 211 
reads aligned to the Mtb reference genome varied considerably (6,736 to 28,090) for 212 
purified DNA extracted from one laboratory and four clinical Mtb culture isolates. 213 
When DNA was extracted directly from two sputum specimens, the number of 214 
mapped Mtb reads was very low (16 and 53), and the majority of the reads produced 215 
corresponded to human DNA.  216 
 217 
The first study of culture-free ONT sequencing of bronchioalveolar lavage and lymph 218 
node aspirates specimens was also published in 2020(12). George et al. achieved a 219 
mean Mtb genome coverage for clinical specimens ranging from 0.55x to 81x. High 220 
(99.9%) consensus accuracy from ONT data was obtained when Nanopolish, a 221 
software package designed to analyse ONT data at the signal-level, was used. 222 












































reads could not be reliably assigned to an input sample. Optimal ONT sequencing 224 
results were thus only achieved when one flow cell was dedicated to a single 225 
sample, rendering this approach prohibitively expensive for routine clinical settings.  226 
 227 
Three studies assessing ONT sequencing for targeted sequencing of drug resistance 228 
loci were all published in 2020(11, 24, 25). Tafess et al. and Chan et al. used 229 
custom-made panels of 19 and 10 drug resistance-associated loci, respectively. 230 
Tafess et al. showed 100% agreement in drug resistance detection between ONT 231 
and Illumina MiSeq when variants with an allele frequency below 40% reported by 232 
ONT sequencing were excluded. Chan et al. showed 95% concordance for ONT 233 
detected variants with an allele frequency of 100% as reported by MiSeq(24, 25). 234 
The cost per sample for sequencing 19 resistance loci developed by Tafess et al. 235 
was 72 USD on the ONT MinION and 68 USD on Illumina MiSeq but the turnaround 236 
time was shorter using the MinION (15 hours) compared to MiSeq (38 hours)(24). 237 
Chan et al. reported similar per sample assay and sequencing costs on the ONT 238 
MinION device (64 USD) when sequencing 24 samples per flow cell(25). Cabibbe et 239 
al. assessed the GenoScreen Deeplex Myc-TB assay and found full concordance in 240 
detecting drug-resistant variants between ONT MinION and Illumina MiniSeq when 241 
applying an allele frequency threshold of 80%. The assay and sequencing costs 242 
were comparable between ONT MinION and Illumina MiniSeq, at approximately 100 243 
Euros per sample(11).  244 
 245 
Software development 246 
Two papers published in 2019 focussed on the use of existing bioinformatic pipelines 247 












































Mtb ONT WGS data(18, 19). Mykrobe predictor was one of the first software 249 
packages for species identification and Mtb drug resistance prediction but the use of 250 
Mykrobe predictor for ONT WGS analysis was not evaluated for Mtb(27). Hunt et al. 251 
assessed Mykrobe, the updated version which features an updated statistical model 252 
for ONT data, updated resistance library, and functionality to use a custom drug 253 
resistance library on five Mtb isolates. Mykrobe detected the exact same resistance 254 
causing mutations from both ONT and Illumina sequence data(19). TBProfiler, 255 
another bioinformatics tool developed to predict drug resistance and infer Mtb 256 
lineage and strain type from Illumina WGS data(28), was updated by Phelan et al. 257 
and adapted to allow the analysis of ONT data(18). TBProfiler analysis of 34 258 
replicates of three multi-drug resistant Mtb isolates showed that one resistance-259 
conferring variant (insertion in the tlyA gene) was missed by analysis of the ONT 260 
MinION data as compared to Illumina data(18).  261 
 262 
Teng et al., developed Chiron as an open-source base-calling algorithm. Chiron 263 
translates raw nanopore current signals directly into nucleotide sequences using 264 
deep learning neural networks(16). Chiron was trained on viral (Escherichia virus 265 
Lambda) and bacterial (Escherichia coli) sequencing reads and allows users to train 266 
the neural network in the software with their own specific genomes of interest (with 267 
distinct characteristics). When used for the base-calling of a single Mtb isolate 268 
sequenced with a MinION device, Chiron was shown to be more accurate than 269 
Albacore V1.1 and nearly as accurate as Albacore V2.0.1 (developed by ONT).  270 
 271 
Finally, Tang et al. performed a small validation study of the MIRUReader software 272 












































repeat (MIRU-VNTR) typing profiles from ONT data(26). MIRUReader was able to 274 
predict the MIRU-VNTR profiles correctly from ONT MinION WGS data of 13 of the 275 
15 Mtb strains assessed and the profiles were identical to those obtained using the 276 
GenoScreen MIRU-VNTR Quadruplex kit.  277 
 278 
Critical evaluation of strengths and limitations of Mtb ONT sequencing  279 
The key strengths of ONT’s sequencing platforms are the low capital investment, 280 
competitive per sample sequencing cost when multiplexing, possibility of PCR-bias 281 
free library preparation, cold-chain-free sequencing reagents, fast turnaround time, 282 
the use of long reads to resolve complex genomic loci, and the ability to investigate 283 
methylation status. 284 
 285 
The main limitation of ONT sequencing remains the suboptimal accuracy. 286 
Sequencing accuracy can be expressed as single read or consensus accuracy. In 287 
2015, the single-read accuracy (or percentage identity of a sequence compared to its 288 
reference sequence) of ONT data was only 60%(10). The low single read accuracy 289 
was due to random read errors. Following changes in flow cell chemistry, 290 
improvements in base-calling software, development of post-sequencing correction 291 
tools, and 2D and 1D2 sequencing, the single read accuracy has increased to >95% 292 
for the latest R10.3 flow cells(9). While this is still lower than the 99,9% accuracy of 293 
short-read Illumina sequencing(29), accuracy data for the latest R10 flow cells (post 294 
R10.3) have not yet been published. Consensus accuracy measures the identity of a 295 
consensus sequence constructed from multiple overlapping reads originating from 296 
the same genomic location, and depends on systematic errors. For Mtb, the 297 












































coverage and 99,92% at 238x coverage(16, 21). As a consensus accuracy of 299 
99,63% would correspond to >15000 errors in the 4.4Mbp Mtb genome, the high 300 
false positive rate of ONT sequencing still remains a barrier for TB-outbreak 301 
investigations. ONT is sensitive to errors in homopolymeric regions(10). When a 302 
stretch of identical k-mers passes the through the nanopore, a window of similar 303 
current signals is generated that complicate the determination of the number of 304 
identical nucleotides that is present. Base-calling of homopolymeric regions larger 305 
than the k-mer length recognized by the nanopore is therefore particularly 306 
challenging(30). This leads mostly to reduced ONT sequence accuracy for insertions 307 
and deletions.  308 
 309 
The current accuracy levels achieved by ONT are likely sufficient to confidently 310 
detect drug-resistance conferring mutations(11, 18, 19, 21, 24), but may be 311 
suboptimal to detect hetero-resistance or mixed infection, and to infer transmission 312 
events. For example, where Illumina WGS data can detect 1% to 3% hetero-313 
resistance at a depth of 400x and 100x, respectively(31), higher allele frequency 314 
thresholds (40%(24) and 80%(11)) for ONT data had to be used to achieve full 315 
concordance with Illumina sequencing for drug-resistance detection. Furthermore, 316 
detection of mixed infection in Illumina WGS data can be done accurately using 317 
QuantTB, which identifies mixed infections based on lineage-specific single 318 
nucleotide variant markers, but this tool has not been validated for ONT data.  319 
 320 
The output and accuracy of ONT flow cells have improved over the past years. Non-321 
specific PCR-based library preparation of sputum spiked with M. bovis BCG purified 322 












































coverage bias and higher data yield using the R9.4 compared to R9 flow cells(7). In 324 
addition, the latest R10.3 ONT flow cells provide further increased throughput and 325 
have a longer signal detection area, therefore improved base-calling can be 326 
achieved. The release of the Flongle adapter in 2019 provides a low-output 327 
sequencing solution (2 Gb) at 90 USD per Flongle flow cell, which is the lowest set-328 
up cost of any sequencing platform currently available. 329 
 330 
Finally, an important limitation to the application of ONT sequencing in Mtb research, 331 
clinical care and public health lies in the limited experience to date with Mtb ONT 332 
sequencing, as ONT data for only 764 Mtb strains have been published by January 333 
20, 2021. 334 
 335 
Future prospects 336 
One of the most promising recent ONT developments is the so-called “Read-Until” 337 
functionality of ONT sequencers. During Read-Until workflows, base-calling and 338 
rapid reference alignment are carried out in real-time, while the DNA or RNA 339 
molecule is passing through the nanopore(9). This sequence information is then 340 
used to decide whether a particular molecule should be sequenced further or ejected 341 
preliminarily from the pore by reversing the voltage. Thus, Read-Until allows 342 
directing more sequencing coverage towards targeted genomes or genomic regions 343 
that are of interest to the investigator. Read-Until currently reaches enrichments of 344 
2.7x to 5.4x, as ejecting the sequencing read comes with a small, but cumulative risk 345 
of blocking the nanopore for the remainder of the sequencing run(32). Hence, the 346 
more selective one is, the more pores are blocked during the sequencing process, 347 












































onboard nucleases that unblock blocked pores may resolve this problem. With 349 
regards to Mtb research and tuberculosis care, Read-Until could greatly advance the 350 
field of WGS directly from sputum or other clinical specimens as these samples 351 
typically have high amounts of human and microbial contaminant DNA compared to 352 
the low copy numbers of Mtb genomes(12). Additionally, Read-Until could be used to 353 
direct more sequencing coverage towards genes conferring drug-resistance in Mtb.  354 
 355 
Another area of TB research where ONT sequencing could play an important role is 356 
epigenetics. The low-cost ONT hardware, development of open-source software to 357 
identify epigenetic base modifications, and long-read PCR-bias free sequencing of 358 
native DNA and RNA make ONT sequencing an attractive alternative for future 359 
epigenetic and multi-omics Mtb investigations(3), but such studies have not yet been 360 
performed. Studies using PacBio sequencing revealed that different methylation 361 
patterns may influence virulence, pathogenicity, and the development of (lineage-362 
specific) drug resistance in Mtb(4). To date, only one study has used PacBio 363 
sequencing to combine genomic, transcriptomic, and methylation analysis of 22 Mtb 364 
isolates. Gomez-Gonzalez et al. found a relationship between DNA sequence, 365 
methylation, and RNA expression(5). Further research is needed to explore the 366 
multi-omics potential of ONT sequencing research and to verify the functional 367 
consequences of the identified mechanisms of gene expression regulation.  368 
 369 
Conclusion 370 
The low capital cost and portable nature of ONT hardware, the simplification and 371 
automation of sample- and library preparation steps when using VolTRAX, and 372 












































value in mycobacteriological research laboratories, especially for detection of drug 374 
resistance. The development of the Read-Until function may accelerate researchers’ 375 
ability to sequence directly from sputum samples. ONT’s long-read sequencing may 376 
expand the research applications in Mtb sequencing beyond what is possible using 377 
short-read sequencing analysis workflows by including epigenetics and 378 
investigations of the role of the repetitive elements and complex regions of the Mtb 379 
genome. The lower per base accuracy levels of ONT sequencing compared to that 380 
of Illumina technologies currently limit its use in the detection of transmission events 381 
and the study of  heteroresistance or mixed infections. Experiences with its 382 
application in public health, clinical care, and Mtb research remain limited and the 383 
lack of consensus in the bioinformatics analysis of Mtb ONT sequence data make its 384 
implementation in clinical care or public health laboratories premature.  385 
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Figure legend: 530 
 531 
Figure 1. Overview of the Mycobacterium tuberculosis sequencing approach 532 
using an Oxford Nanopore Technologies sequencing platform. After DNA 533 
extraction, usually from cultured Mtb but in some cases directly from clinical 534 
specimens, ONT library preparation is done, which may include barcoding and/or 535 
PCR amplification of the sequence library. The prepared library is loaded on the flow 536 
cell inserted in the sequencer that is connected to a computer. During the ONT 537 
sequencing process, the current signal is detected and these data are stored in the 538 
FAST5 format. If live base-calling is enabled, the optional and new Read-Until 539 
function can be used to selectively sequence nucleic acid molecules of interest. 540 
Base-called sequences are stored in the FASTQ format, which is analysed 541 
bioinformatically. Mtb ONT sequencing has applications in fundamental research, 542 
clinical care and public health. Abbreviations: Mtb: Mycobacterium tuberculosis, 543 















































Table 1. Publications using Oxford Nanopore Technologies sequencing data for Mycobacterium tuberculosis 548 
First 
author  


















































2018 (21) WGS Clinical, 
cultured 
isolate 









an XDR Mtb 
genome  
Identification of 
known and novel 
genomic variants 
Smith 2020 (23) WGS Clinical, 
cultured 
isolates 
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Number of Mtb 
reads varied 
considerably and 
was very low for 
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4 cultured 
isolates,        
2 specimens 
6 application uncultured Mtb extracted directly 
from sputum 






















Use of a low-
cost thermo-
protection buffer 
and a single 
flow cell per 
sample resulted 
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and Illumina for 
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To evaluate the 
compatibility of 
Deeplex Myc-
TB, with ONT 
MinION. 
ONT MinION and 
Illumina MiniSeq 




*N refers to the number of sequenced samples. #20 replicates of one sample. Abbreviations: WGS: whole genome sequencing; 549 
BCG: Bacillus Calmette-Guérin; ONT: Oxford Nanopore Technologies; PCR: polymerase chain reaction; XDR: extensively drug 550 












































Table 2. Published software for analysis of Mycobacterium tuberculosis 552 
Oxford Nanopore Technologies sequence data 553 
All publications listed used Mtb WGS generated using an ONT MinION device. 554 
Abbreviations: Mtb: Mycobacterium tuberculosis; ONT: Oxford Nanopore 555 
Technologies; MIRU-VNTR: mycobacterial interspersed repetitive unit - variable 556 




Year Reference Name Purpose Number of samples 
Hunt 2019 (19) Mykrobe Drug resistance prediction, 
species identification 
5 Mtb clinical isolates 
Phelan 2019 (18) TBProfiler Drug resistance prediction, 
Mtb lineage assignment 
34 replicates of 3 Mtb 
clinical isolates 
Teng 2018 (16) Chiron ONT sequencing base-caller 1 Mtb clinical isolate 
Tang 2020 (26) MIRUReader In silico MIRU-VNTR from 
long-read Mtb sequencing 
data 
15 Mtb clinical isolates 
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